Literature DB >> 2860567

Phagosome acidification blocked by intracellular Toxoplasma gondii.

L D Sibley, E Weidner, J L Krahenbuhl.   

Abstract

Toxoplasma gondii belongs to a group of highly virulent intracellular parasites that reside in host cell vacuoles which resist typical phagosome-lysosome fusion. Live Toxoplasma replicate prodigiously within modified phagocytic vacuoles formed during invagination of the host plasma membrane. In contrast, heat-killed Toxoplasma or specific antibody (heat-inactivated)-coated live Toxoplasma-containing vacuoles readily undergo lysosome fusion and digestion in normal macrophages. Of newly recognized significance to Toxoplasma survival is the microbicidal effect of phagosome acidification, which reportedly can occur independently of fusion with other acidic vesicles. We report here that modified live Toxoplasma-containing vacuoles fail to acidify in normal macrophages, as indicated by the sensitive pH probe fluorescein. In contrast, when live Toxoplasma are coated with specific antibody (heat-inactivated), they trigger phagosome acidification when entering normal macrophages. A similar acidification is observed when normal phagocytes ingest dead Toxoplasma. Extracellular Toxoplasma are highly susceptible to acidic pH conditions, indicating that the acidification block in the modified vacuoles may be important for intracellular survival.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860567     DOI: 10.1038/315416a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  78 in total

1.  Transmembrane insertion of the Toxoplasma gondii GRA5 protein occurs after soluble secretion into the host cell.

Authors:  L Lecordier; C Mercier; L D Sibley; M F Cesbron-Delauw
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

2.  Differential infectivity and division of Toxoplasma gondii in human peripheral blood leukocytes.

Authors:  J Y Channon; R M Seguin; L H Kasper
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

Review 3.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 4.  Lytic cycle of Toxoplasma gondii.

Authors:  M W Black; J C Boothroyd
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

5.  Attachment ligands of viable Toxoplasma gondii induce soluble immunosuppressive factors in human monocytes.

Authors:  J Y Channon; E I Suh; R M Seguin; L H Kasper
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

6.  Mechanism of entry determines the ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production.

Authors:  Barbara A Butcher; Eric Y Denkers
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

7.  Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting.

Authors:  Nicole Joller; Stefan S Weber; Andreas J Müller; Roman Spörri; Petra Selchow; Peter Sander; Hubert Hilbi; Annette Oxenius
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-03       Impact factor: 11.205

Review 8.  Role of autophagy in the host response to microbial infection and potential for therapy.

Authors:  Mario Fabri; Susan E Realegeno; Eun-Kyeong Jo; Robert L Modlin
Journal:  Curr Opin Immunol       Date:  2010-11-09       Impact factor: 7.486

Review 9.  Survival of protozoan intracellular parasites in host cells.

Authors:  Patrícia Leirião; Cristina D Rodrigues; Sónia S Albuquerque; Maria M Mota
Journal:  EMBO Rep       Date:  2004-12       Impact factor: 8.807

10.  p47 GTPases regulate Toxoplasma gondii survival in activated macrophages.

Authors:  Barbara A Butcher; Robert I Greene; Stanley C Henry; Kimberly L Annecharico; J Brice Weinberg; Eric Y Denkers; Alan Sher; Gregory A Taylor
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.